Eccogene, Inc., a research driven biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced today the addition of Michael R. Wiley, Ph.D., to its scientific advisory board. Dr. Wiley earned his PhD in chemistry from University of Utah and finished postdoctoral training at Columbia University. He is a well-recognized drug discoveryRead More
